Ospedale Maggiore Policlinico News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ospedale maggiore policlinico. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ospedale Maggiore Policlinico Today - Breaking & Trending Today

Five-Day Antibiotic Course Noninferior for Pediatric Febrile UTI

The recurrence rate of fUTI within 30 days from the end of therapy was 1.4 and 5.7% in the short and standard groups, respectively. ....

Ospedale Maggiore Policlinico , Giovanni Montini , Healthday News ,

Five-day antibiotic course noninferior for pediatric febrile UTI

Five-day antibiotic course noninferior for pediatric febrile UTI
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Charlesr Woods , Ospedale Maggiore Policlinico , Giovanni Montini , Short Oral Antibiotic Therapy , Pediatric Febrile Urinary Tract Infections , Randomized Trial , Are We Ready , Short Antibiotic Courses , Febrile Urinary Tract Infections ,

Continuing, Stopping Immunosuppression Tested in Lupus Nephritis

Risk of renal relapse and SLE flares was greater in patients with lupus nephritis who discontinued rather than continued immunosuppressive therapy. ....

Christophe Richez , Vifor Pharma , Noemie Jourde Chiche , Hospitalier Pellegrin , Ospedale Maggiore Policlinico , European Congress , Marseille France University , Fresenius Medical Care , Groupe Hospitalier , Lupus Nephritis , Activity Index , Discontinuation Versus Continuation Not Shown , Fresenius Medical , Systemic Lupus Erythematosus , End Stage Renal Disease Esrd , End Stage Renal Disease , Immunosuppressive Therapy , Immunosuppressive Agents , Immunosuppressive Drugs , Rug Immunosuppressive , Social Issues ,

Frontiers | Factors Associated With Severity of Delirium Complicating COVID-19 in Intensive Care Units

The clinical outcome of the disease provoked by the Sars-CoV-2 infection, COVID-19, is largely due to the development of interstitial pneumonia accompanied by an Acute Respiratory Distress Syndrome (ARDS), often requiring ventilatory support therapy in Intensive Care Units (ICUs). Current epidemiologic evidence is demonstrating that the COVID-19 prognosis is significantly influenced by its acute complications. Among these, delirium figures as one of the most frequent and severe, especially in the emergency setting, where it shows a significantly negative prognostic impact. In this regard, the aim of our study is to identify clinical severity factors of delirium complicating COVID-19 related-ARDS. We performed a comparative and correlation analysis using demographics, comorbidities, multisystemic and delirium severity scores and anti-delirium therapy in two cohorts of ARDS patients with delirium respectively due to COVID-19 (n=40) or other medical conditions (n=39). Our results indicate ....

United States , Sachsen Anhalt , Ospedale Maggiore Policlinico , Paolo Brambilla , Anesth Analg , Granda Ospedale Maggiore Policlinico , American Psychiatric Association , Definition Task , Group Correlations , World Health Organization , Ethics Committee Milan Area , Care Study Group , Brain Behav Immun Health , American Psychiatric Publishing Inc , Ethics Committee Of The Fondazione , Intensive Care Units , Respiratory Syndrome Coronavirus , Middle East Respiratory Syndrome Coronavirus , Acute Respiratory Distress Syndrome , Psychiatry Unit , Ospedale Maggiore , Ethics Committee , Ospedale Maggiore Policlinico Intensive Care Unit , Organ Failure Assessment , Confusion Assessment Method , Microsoft Excel ,

Eiger BioPharmaceuticals Announces First Patient Enrolled in LIMT-2: A Phase 3 Study of Peginterferon Lambda in Patients with Chronic Hepatitis Delta Virus (HDV) Infection

/PRNewswire/ Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies. ....

Ospedale Maggiore Policlinico , Pietro Lampertico , David Cory , Bristol Myers Squibb , Hepatology Division , European Medicines Agency , Drug Administration , Eiger Biopharmaceuticals Inc , University Of Milan , Eiger Biopharmaceuticals , Hepatitis Delta Virus , Peginterferon Lambda , Liver Disease , Durable Virologic Response , Orphan Designation , Fast Track , Breakthrough Therapy Designation , Private Securities Litigation Reform Act , Quarterly Report ,